Analytical Data
-
Gene name
BGLF2
- Application
-
Alternative Names
BGLF2；Non-receptor tyrosine-Protein kinase TYK2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0CK53
-
Expression Region
1-336aa
-
AA Sequence
MASAANSSREQLRKFLNKECLWVLSDASTPQMKVYTATTAVSAVYVPQIAGPPKTYMNVTLIVLKPKKKPTYVTVYINGTLATVARPEVLFTKAVQGPHSLTLMYFGVFSDAVGEAVPVEIRGNPVVTCTDLTTAHVFTTSTAVKTVEELQDITPSEIIPLGRGGAWYAEGALYMFFVNMDMLMCCPNMPTFPSLTHFINLLTRCDNGECVTCYGAGAHVNILRGWTEDDSPGTSGTCPCLLPCTALNNDYVPITGHRALLGLMFKPEDAPFVVGLRFNPPKMHPDMSRVLQGVLANGKEVPCTAQPWTLLRFSDLYSRAMLYNCQVLKRQVLHSY
-
Molecular Weight
44.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BGLF2 is a protein encoded by the Epstein-Barr virus (EBV), a member of the herpesvirus family, which is linked to various human diseases, including infectious mononucleosis and certain cancers. The BGLF2 protein is particularly interesting due to its role in viral replication and its function as a glycoprotein involved in viral assembly and release. Research into BGLF2 focuses on its structural properties, interactions with other viral and host proteins, and its potential as a target for antiviral therapies. Understanding BGLF2's mechanisms could reveal insights into EBV pathogenesis and provide strategies to mitigate EBV-related diseases. With its dual role in both viral life cycle and immune evasion, BGLF2 serves as a crucial component for investigating new therapeutic approaches, including vaccines and antiviral drugs. The ongoing study of BGLF2 contributes significantly to the broader field of virology, particularly in the context of understanding how herpesviruses persist in the host and evade immune responses, thereby underscoring its relevance in medical research and potential clinical applications.
